Metal-free salan-type compound induces apoptosis and overcomes multidrug resistance in leukemic and lymphoma cells in vitro
We report on our preclinical findings of a simple salicylic diamine compound (THG 1213) which has yielded exceptional results as a potential chemotherapeutic drug. THG 1213 is an easy to synthesize chiral and metal-free salan compound.
THG 1213 was tested on several leukemia, lymphoma and solid tumor cell lines in vitro. The effects have been studied by LDH release essay, FACS flow cytometry, photometric cell count, immunoblotting, and NMR spectroscopy.
THG 1213 selectively inhibits proliferation and induces apoptosis in leukemia, lymphoma and solid tumor cell lines. Necrosis or effects on healthy leucocytes could not be detected. Apoptosis is induced via the intrinsic and extrinsic pathways. The salan THG 1213 overcomes multidrug resistance in tumor cells and acts synergistically with vincristine and daunorubicin.
THG 1213 displays remarkable antitumor properties. In particular, the lack of metallic components of THG 1213 could prove to be beneficial in future clinical trials, as metal-containing drugs are known to show severe side effects.
KeywordsCancer Leukemia Multidrug resistance Apoptosis Salan
Financial support from the Fonds der Chemischen Industrie, as well as the Robert-Koch foundation (Berlin) and the Dr. Kleist Foundation (Berlin) is gratefully acknowledged. We thank Lea Reichel for her contribution.
Financial support from the Fonds der Chemischen Industrie, as well as the Robert-Koch foundation (Berlin) and the Dr. Kleist Foundation (Berlin) is gratefully acknowledged.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- Berkessel A, Brandenburg M, Schäfer M (2008) Mass-spectrometric and kinetic studies on the mechanism and degradation pathways of titanium salalen catalysts for asymmetric epoxidation with aqueous hydrogen peroxide. Adv Synth Catal 350:1287–1294. https://doi.org/10.1002/adsc.200700601 CrossRefGoogle Scholar
- Feng J, Lu X, Wang G et al (2012) The syntheses and characterizations of molybdenum(vi) complexes with catechol and 2,3-dihydroxynaphthalene, and the structure–effect relationship in their in vitro anticancer activities. Dalton Trans 41:8697–8702. https://doi.org/10.1039/C2DT30395G CrossRefPubMedGoogle Scholar
- Klajner M, Licona C, Fetzer L et al (2014) Subcellular localization and transport kinetics of ruthenium organometallic anticancer compounds in living cells: a dose-dependent role for amino acid and iron transporters. Inorg Chem 53:5150–5158. https://doi.org/10.1021/ic500250e CrossRefPubMedGoogle Scholar
- Pereira CCL, Diogo CV, Burgeiro A et al (2008) Complex formation between heptakis(2,6-di-O-methyl)-β-cyclodextrin and cyclopentadienyl molybdenum(II) dicarbonyl complexes: structural studies and cytotoxicity evaluations. Organometallics 27:4948–4956. https://doi.org/10.1021/om800413w CrossRefGoogle Scholar